Cargando…

Mitochondrial Contribution to Parkinson's Disease Pathogenesis

The identification of the etiologies and pathogenesis of Parkinson's disease (PD) should play an important role in enabling the development of novel treatment strategies to prevent or slow the progression of the disease. The last few years have seen enormous progress in this respect. Abnormalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schapira, Anthony H. V., Gegg, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109314/ https://www.ncbi.nlm.nih.gov/pubmed/21687805 http://dx.doi.org/10.4061/2011/159160

Ejemplares similares

Mitochondrial dysfunction associated with glucocerebrosidase deficiency
por: Gegg, Matthew E., et al.
Publicado: (2016)

Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin‐mediated mitophagy
por: Ivankovic, Davor, et al.
Publicado: (2015)

Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
por: Abramov, Andrey Yurevich, et al.
Publicado: (2011)

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
por: Magalhaes, Joana, et al.
Publicado: (2016)

Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells
por: Gegg, Matthew E., et al.
Publicado: (2009)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

No evidence for substrate accumulation in Parkinson brains with GBA mutations
por: Gegg, Matthew E., et al.
Publicado: (2015)

Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
por: Sanchez-Martinez, Alvaro, et al.
Publicado: (2016)

GBA Variants and Parkinson Disease: Mechanisms and Treatments
por: Smith, Laura, et al.
Publicado: (2022)

Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons
por: Gegg, Matthew E, et al.
Publicado: (2020)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease
por: Osellame, Laura D., et al.
Publicado: (2013)

Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease
por: Wang, Rui, et al.
Publicado: (2020)

Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease
por: Cabezas-Opazo, Fabian A., et al.
Publicado: (2015)

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
por: McNeill, Alisdair, et al.
Publicado: (2014)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Recent developments in biomarkers in Parkinson disease
por: Schapira, Anthony H.V.
Publicado: (2013)

The importance of being connected: membrane contact sites and Parkinson’s disease
por: Gegg, Matthew E.
Publicado: (2023)

Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation
por: Yang, Shi-yu, et al.
Publicado: (2020)

Ambroxol reverses tau and α-synuclein accumulation in a cholinergic N370S GBA1 mutation model
por: Yang, Shi Yu, et al.
Publicado: (2022)

Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson’s Disease
por: Scott-Massey, Andie, et al.
Publicado: (2022)

The relationship between glucocerebrosidase mutations and Parkinson disease
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Endoplasmic reticulum and lysosomal Ca(2+) stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts
por: Kilpatrick, Bethan S., et al.
Publicado: (2016)

Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease
por: Sato, Shigeto, et al.
Publicado: (2011)

Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease
por: Jiang, Xue, et al.
Publicado: (2019)

The role of DJ-1 complexes and catecholamine metabolism: relevance for familial and idiopathic Parkinson’s disease
por: Piston, Dominik, et al.
Publicado: (2018)

Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?
por: Clark, Joanne, et al.
Publicado: (2011)

The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
por: Smith, Laura J, et al.
Publicado: (2022)

The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance
por: Menozzi, Elisa, et al.
Publicado: (2021)

Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach
por: Menozzi, Elisa, et al.
Publicado: (2023)

Exploring the Genotype–Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers
por: Menozzi, Elisa, et al.
Publicado: (2021)

Astrocytic Oxidative/Nitrosative Stress Contributes to Parkinson’s Disease Pathogenesis: The Dual Role of Reactive Astrocytes
por: Rizor, Asha, et al.
Publicado: (2019)

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
por: Cacabelos, Ramón
Publicado: (2017)

Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models
por: Hong, Chien Tai, et al.
Publicado: (2016)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease
por: Dolgacheva, Lyudmila P., et al.
Publicado: (2022)

Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
por: Pons-Espinal, Meritxell, et al.
Publicado: (2020)

Somatic Alpha-Synuclein Mutations in Parkinson's Disease: Hypothesis and Preliminary Data
por: Proukakis, Christos, et al.
Publicado: (2013)

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
por: Villavicencio Tejo, Francisca, et al.
Publicado: (2021)

Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment
por: Liu, Jia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ts51712i8vck8jhrp9f6g7fb25